[ALNY] YoY Quarter Result on 30-Sep-2013 [#Q3]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
07-Nov-2013
Financial Year
2013
Quarter
30-Sep-2013 [#Q3]
Profit Trend
QoQ- -63.39%
YoY- -52.22%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
Revenue 13,651 6,324 10,972 8,991 16,759 20,791 27,668 -11.09%
PBT -104,071 -76,792 -43,922 -31,956 -19,502 -13,237 -9,332 49.41%
Tax -2,204 -1,610 67 -2,270 -2,543 -930 298 -
NP -104,071 -76,792 -43,989 -29,686 -19,502 -13,237 -9,630 48.63%
Tax Rate - - - - - - - -
Total Cost 117,722 83,116 54,961 38,677 36,261 34,028 37,298 21.09%
Ratio Analysis
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
NP Margin -762.37 -1,214.29 -400.92 -330.17 -116.37 -63.67 -34.81 67.18%
Per Share
30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 CAGR
EPS -1.21 -0.91 -0.58 -0.48 -0.38 -0.31 -0.23 31.84%
EPS Diluted -1.21 -0.91 -0.58 -0.48 -0.38 -0.31 -0.23 31.84%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.